Barbara specialises in providing counsel and litigation services in Dutch and European patent law. Her expertise primarily focuses on pharmaceutical inventions, medical devices and biotech. She also handles cases on procedural issues and evidence-related measures.
One of the ‘Key Lawyers’ in patent law
Barbara has valuable practical experience through her involvement in complex patent proceedings at both the District Court and the Court of Appeal in The Hague. Her contributions in the field have earned her recognition as one of Brinkhof’s ‘Key Lawyers’ in patent law by The Legal 500.
Experience & ancillary activities
Barbara publishes articles and regularly contributes to books and blogs on patent law. She is an active member of AIPPI, ChIPs and Young EPLAW. Before starting her Law studies, Barbara graduated cum laude with a BSc in Cosmetic Science, focusing on chemistry and product development. She then worked for almost two years in Unilever’s R&D department, where she helped develop and launch new products. In 2019, she obtained her Master’s in Information Law from the University of Amsterdam. Barbara has worked at Brinkhof since 2019 and was admitted to the Dutch bar in February 2020.
Some of the cases Barbara Mooij has handled:
- representing Accord in various pharmaceutical cases, including in connection with cinacalcet;
- representing Gedeon Richter in an international dispute concerning their adalimumab patent.